Company profile GOVX
There is not enough data for GeoVax Labs -phase 2 to provide analysis
There is not enough data for GeoVax Labs -phase 2 to provide correlation calculation
There is not enough data for GeoVax Labs -phase 2 to provide analysis
After 39 days of this quarter the interest is at 152.0. Based on that we can calculate that during remaining 52 days it will total up to 355.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 424 | 282 -33.5% QoQ | 444 57.4% QoQ | 308 -30.6% QoQ |
| 2020 | 403 -5.0% YoY 30.8% QoQ | 366 29.8% YoY -9.2% QoQ | 469 5.6% YoY 28.1% QoQ | 454 47.4% YoY -3.2% QoQ |
| 2021 | 404 0.2% YoY -11.0% QoQ | 465 27.0% YoY 15.1% QoQ | 377 -19.6% YoY -18.9% QoQ | 401 -11.7% YoY 6.4% QoQ |
| 2022 | 539 33.4% YoY 34.4% QoQ | 458 -1.5% YoY -15.0% QoQ | 443 17.5% YoY -3.3% QoQ | 420 4.7% YoY -5.2% QoQ |
| 2023 | 334 -38.0% YoY -20.5% QoQ | 370 -19.2% YoY 10.8% QoQ | 528 19.2% YoY 42.7% QoQ | 474 12.9% YoY -10.2% QoQ |
| 2024 | 152 -54.5% YoY -67.9% QoQ | - | - | - |
The average 5 years interest of head and neck squamous cell carcinoma was 32.62 per week. The last year interest of head and neck squamous cell carcinoma compared to the last 5 years has changed by 0.0%. The interest for head and neck squamous cell carcinoma is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 4.05%.
After 39 days of this quarter the interest is at 37.0. Based on that we can calculate that during remaining 52 days it will total up to 86.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 44 | 65 47.7% QoQ | 62 -4.6% QoQ | 67 8.1% QoQ |
| 2020 | 99 125.0% YoY 47.8% QoQ | 132 103.1% YoY 33.3% QoQ | 88 41.9% YoY -33.3% QoQ | 316 371.6% YoY 259.1% QoQ |
| 2021 | 229 131.3% YoY -27.5% QoQ | 268 103.0% YoY 17.0% QoQ | 234 165.9% YoY -12.7% QoQ | 163 -48.4% YoY -30.3% QoQ |
| 2022 | 288 25.8% YoY 76.7% QoQ | 126 -53.0% YoY -56.2% QoQ | 110 -53.0% YoY -12.7% QoQ | 106 -35.0% YoY -3.6% QoQ |
| 2023 | 107 -62.8% YoY 0.9% QoQ | 98 -22.2% YoY -8.4% QoQ | 92 -16.4% YoY -6.1% QoQ | 104 -1.9% YoY 13.0% QoQ |
| 2024 | 37 -65.4% YoY -64.4% QoQ | - | - | - |
The average 5 years interest of HIV vaccine was 10.86 per week. The last year interest of HIV vaccine compared to the last 5 years has changed by -31.12%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 44.12%.
After 39 days of this quarter the interest is at 45.0. Based on that we can calculate that during remaining 52 days it will total up to 105.0. malaria vaccine expected interest is significantly higher compared to same quarter last year (+47.9%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 44 | 98 122.7% QoQ | 61 -37.8% QoQ | 59 -3.3% QoQ |
| 2020 | 257 484.1% YoY 335.6% QoQ | 114 16.3% YoY -55.6% QoQ | 45 -26.2% YoY -60.5% QoQ | 48 -18.6% YoY 6.7% QoQ |
| 2021 | 58 -77.4% YoY 20.8% QoQ | 83 -27.2% YoY 43.1% QoQ | 62 37.8% YoY -25.3% QoQ | 187 289.6% YoY 201.6% QoQ |
| 2022 | 69 19.0% YoY -63.1% QoQ | 83 0.0% YoY 20.3% QoQ | 66 6.5% YoY -20.5% QoQ | 70 -62.6% YoY 6.1% QoQ |
| 2023 | 71 2.9% YoY 1.4% QoQ | 132 59.0% YoY 85.9% QoQ | 119 80.3% YoY -9.8% QoQ | 99 41.4% YoY -16.8% QoQ |
| 2024 | 45 -36.6% YoY -54.5% QoQ | - | - | - |
The average 5 years interest of malaria vaccine was 7.16 per week. The last year interest of malaria vaccine compared to the last 5 years has changed by 15.78%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 52.95%.
After 39 days of this quarter the interest is at 47.0. Based on that we can calculate that during remaining 52 days it will total up to 110.0. Ebola vaccine expected interest is significantly higher compared to previous quarter (+124.5%) and same quarter last year (+57.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 50 | 146 192.0% QoQ | 98 -32.9% QoQ | 146 49.0% QoQ |
| 2020 | 499 898.0% YoY 241.8% QoQ | 404 176.7% YoY -19.0% QoQ | 159 62.2% YoY -60.6% QoQ | 209 43.2% YoY 31.4% QoQ |
| 2021 | 274 -45.1% YoY 31.1% QoQ | 169 -58.2% YoY -38.3% QoQ | 150 -5.7% YoY -11.2% QoQ | 129 -38.3% YoY -14.0% QoQ |
| 2022 | 96 -65.0% YoY -25.6% QoQ | 77 -54.4% YoY -19.8% QoQ | 55 -63.3% YoY -28.6% QoQ | 93 -27.9% YoY 69.1% QoQ |
| 2023 | 70 -27.1% YoY -24.7% QoQ | 46 -40.3% YoY -34.3% QoQ | 46 -16.4% YoY 0.0% QoQ | 49 -47.3% YoY 6.5% QoQ |
| 2024 | 47 -32.9% YoY -4.1% QoQ | - | - | - |
The average 5 years interest of Ebola vaccine was 11.54 per week. The last year interest of Ebola vaccine compared to the last 5 years has changed by -62.05%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -58.21%.
After 39 days of this quarter the interest is at 99.0. Based on that we can calculate that during remaining 52 days it will total up to 231.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 192 | 349 81.8% QoQ | 133 -61.9% QoQ | 213 60.2% QoQ |
| 2020 | 522 171.9% YoY 145.1% QoQ | 429 22.9% YoY -17.8% QoQ | 232 74.4% YoY -45.9% QoQ | 361 69.5% YoY 55.6% QoQ |
| 2021 | 442 -15.3% YoY 22.4% QoQ | 374 -12.8% YoY -15.4% QoQ | 326 40.5% YoY -12.8% QoQ | 252 -30.2% YoY -22.7% QoQ |
| 2022 | 223 -49.5% YoY -11.5% QoQ | 175 -53.2% YoY -21.5% QoQ | 134 -58.9% YoY -23.4% QoQ | 148 -41.3% YoY 10.4% QoQ |
| 2023 | 194 -13.0% YoY 31.1% QoQ | 203 16.0% YoY 4.6% QoQ | 168 25.4% YoY -17.2% QoQ | 216 45.9% YoY 28.6% QoQ |
| 2024 | 99 -49.0% YoY -54.2% QoQ | - | - | - |
The average 5 years interest of Zika vaccine was 20.63 per week. The last year interest of Zika vaccine compared to the last 5 years has changed by -28.79%. The interest for Zika vaccine is significantly decreasing. The last year interest is quite lower compared to 5 years ago. It has decreased by -25.13%.
After 39 days of this quarter the interest is at 159.0. Based on that we can calculate that during remaining 52 days it will total up to 371.0. Lassa fever vaccine expected interest is significantly higher compared to previous quarter (+110.8%) and same quarter last year (+204.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 131 | 107 -18.3% QoQ | 82 -23.4% QoQ | 118 43.9% QoQ |
| 2020 | 146 11.5% YoY 23.7% QoQ | 135 26.2% YoY -7.5% QoQ | 0 -100.0% YoY -100.0% QoQ | 52 -55.9% YoY inf% QoQ |
| 2021 | 106 -27.4% YoY 103.8% QoQ | 267 97.8% YoY 151.9% QoQ | 127 inf% YoY -52.4% QoQ | 53 1.9% YoY -58.3% QoQ |
| 2022 | 89 -16.0% YoY 67.9% QoQ | 213 -20.2% YoY 139.3% QoQ | 112 -11.8% YoY -47.4% QoQ | 50 -5.7% YoY -55.4% QoQ |
| 2023 | 122 37.1% YoY 144.0% QoQ | 51 -76.1% YoY -58.2% QoQ | 248 121.4% YoY 386.3% QoQ | 176 252.0% YoY -29.0% QoQ |
| 2024 | 159 30.3% YoY -9.7% QoQ | - | - | - |
The average 5 years interest of Lassa fever vaccine was 9.75 per week. The last year interest of Lassa fever vaccine compared to the last 5 years has changed by 37.23%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 43.1%.
There is not enough data for GeoVax Labs contact to provide analysis
There is not enough data for GeoVax Labs contact to provide correlation calculation
There is not enough data for GeoVax Labs contact to provide analysis
There is not enough data for GeoVax Labs headquarters to provide analysis
There is not enough data for GeoVax Labs headquarters to provide correlation calculation
There is not enough data for GeoVax Labs headquarters to provide analysis